DNSP-11
11-amino-acid peptide derived from the prohormone region of preprodopamine (pro-PRO-D peptide). Pre-clinical neuroprotection for dopaminergic neurons in Parkinson's models.
DNSP-11 is a tiny peptide derived from the precursor of dopamine. It protects dopaminergic neurons in Parkinson's animal models. Pre-clinical research only — there is no human protocol, and dosing community vendors sell does not match clinical trial material.
Not FDA approved. Pre-clinical.
Not formally categorized in the FDA bulks lists.
Not prescribed in conventional medicine.
Who it's for
- →Researchers studying Parkinson's disease pathways
- →Neurodegeneration research contexts
- →Educational reference — limited human data
What to expect
- Week 1
Subtle. No published human user-reports of acute effect.
- Week 4
Animal-model neuroprotection markers shift here.
- Week 8
No long-term human data exists.
How it works (mechanism)
11-amino-acid peptide derived from the prohormone region of preprodopamine. Pre-clinical neuroprotection via mechanisms that may include direct neurotrophic action on dopaminergic neurons.
Dosing protocol
No standardized human protocol. Animal-model dosing varies. Community use is highly experimental.
Stacks well with
Side effects
When NOT to use
- ⚠Active psychiatric medication regimen affecting dopamine
- ⚠Pregnancy / nursing
- ⚠Anyone risk-averse to pre-clinical compounds
Common mistakes
- • Treating it as Parkinson's treatment (it's pre-clinical research)
- • Stacking it with dopamine agonists
- • Long cycles without safety data
Educational only. User-specific dosing is between you and a qualified provider.
Frequently asked
What is DNSP-11?+
Is DNSP-11 FDA approved?+
Is DNSP-11 banned by WADA?+
Are you still natty after taking DNSP-11?+
Do doctors prescribe DNSP-11?+
What's the typical dose of DNSP-11?+
What are the side effects of DNSP-11?+
How long until DNSP-11 starts working?+
More in Nootropic
The 'bonding hormone' you make naturally. Synthetic oxytocin is FDA-approved for labor; off-label use covers social, anxiety, and intimacy contexts.
Porcine brain-derived peptide complex. Used clinically in 50+ countries (Russia, China, Mexico, EU) for stroke recovery, TBI, and Alzheimer's. Mixture of low-molecular-weight peptides, not a single compound.
Russian-origin nootropic peptide. Alert/focus end of the spectrum. Pairs with Selank for a balanced cognitive stack.
Angiotensin IV analog with strong synaptogenic effect in animal models. Often-cited as 'BDNF on steroids.' Very limited human data.